Suppr超能文献

critically 评价 重症监护 药物治疗 临床实践指南 的 质量 和 推荐意见 的 强度 。

A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations.

机构信息

Department of Pharmacy, Capital District Health Authority, College of Pharmacy, Dalhousie University, c/o Rm 2043 Victoria Building, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada.

Department of Pharmacy, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.

出版信息

Intensive Care Med. 2010 Oct;36(10):1636-1643. doi: 10.1007/s00134-010-1786-8. Epub 2010 Mar 9.

Abstract

OBJECTIVE

Clinical practice guideline (CPG) quality assessment is important before applying their recommendations. Determining whether recommendation strength is consistent with supporting quality of evidence is also essential. We aimed to determine quality of critical care pharmacotherapy CPGs and to assess whether high quality evidence supports strong pharmacotherapy recommendations.

METHODS

MEDLINE (1966-February 2008), EMBASE (1980-February 2008), National Guideline Clearinghouse (February 2008) and personal files were searched to identify CPGs. Four appraisers evaluated each guideline using the appraisal of guidelines, research and evaluation (AGREE) instrument. AGREE assesses 23 items in six domains that include scope/purpose, stakeholder involvement, rigor of development, clarity, applicability and editorial independence. Standardized domain scores (0-100%) were determined to decide whether to recommend a guideline for use. One appraiser extracted strong pharmacotherapy recommendations and supporting evidence quality.

RESULTS

Twenty-four CPGs were included. Standardized domain scores were clarity [69% (95% confidence interval (CI) 62-76%)], scope/purpose [62% (95% CI 55-68%)], rigor of development [51% (95% CI 42-60%)], editorial independence [39% (95% CI 26-52%)], stakeholder involvement [32% (95% CI 26-37%)] and applicability [19% (95% CI 12-26%)]. The proportion of guidelines that could be strongly recommended, recommended with alterations and not recommended was 25, 37.5 and 37.5%, respectively. High quality evidence supported 36% of strong pharmacotherapy recommendations.

CONCLUSION

Variation in AGREE domain scores explain why one-third of critical care pharmacotherapy CPGs cannot be recommended. Only one-third of strong pharmacotherapy recommendations were supported by high quality evidence. We recommend appraisal of guideline quality and the caliber of supporting evidence prior to applying recommendations.

摘要

目的

临床实践指南(CPG)质量评估在应用其建议之前非常重要。确定推荐强度是否与支持证据的质量一致也是至关重要的。我们的目的是确定重症监护药理学 CPG 的质量,并评估高质量证据是否支持强有力的药理学建议。

方法

使用 MEDLINE(1966 年-2008 年 2 月)、EMBASE(1980 年-2008 年 2 月)、国家指南清理中心(2008 年 2 月)和个人档案搜索以确定 CPG。四名评估员使用评估指南、研究和评估(AGREE)工具评估每个指南。AGREE 评估六个领域中的 23 个项目,包括范围/目的、利益相关者参与、制定的严谨性、清晰度、适用性和编辑独立性。确定标准化的领域分数(0-100%),以决定是否推荐使用指南。一名评估员提取强有力的药理学建议和支持证据的质量。

结果

共纳入 24 项 CPG。标准化的领域分数为清晰度[69%(95%置信区间(CI)62-76%)]、范围/目的[62%(95%CI 55-68%)]、制定的严谨性[51%(95%CI 42-60%)]、编辑独立性[39%(95%CI 26-52%)]、利益相关者参与[32%(95%CI 26-37%)]和适用性[19%(95%CI 12-26%)]。可以强烈推荐、推荐修改和不推荐的指南比例分别为 25%、37.5%和 37.5%。高质量证据支持 36%的强有力的药理学建议。

结论

AGREE 领域分数的差异解释了为什么三分之一的重症监护药理学 CPG 不能被推荐。只有三分之一的强有力的药理学建议得到高质量证据的支持。我们建议在应用建议之前评估指南的质量和支持证据的水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验